Inokuchi Ryota, Hara Yoshitaka, Yasuda Hideo, Itami Noritomo, Terada Yoshio, Doi Kent
Clin Nephrol. 2017 Oct;88(10):167-182. doi: 10.5414/CN109011.
No comprehensive review has examined the difference between community-acquired (CA) and hospital-acquired (HA) acute kidney injury (AKI) in terms of patient characteristics, in-hospital mortality, and hospital stay length.
We conducted a systematic review and meta-analysis of observational studies, using MEDLINE, EMBASE, Web of Science, Google Scholar, and the Cochrane Library from their inceptions to April 10, 2016. Observational studies that (1) were published in peer-reviewed journals; (2) compared CA-AKI with HA-AKI, irrespective of the AKI definition during the same period; and (3) investigated in-hospital mortality and length of hospital stay were studied. Differences in the patients' baseline characteristics were analyzed, and a meta-analysis was conducted to compare the in-hospital mortality and length of hospital stay.
Eight eligible observational studies with 17,939 patients were included. The systematic review showed that patients with CA-AKI had a significantly higher rate of AKI stage 3 compared with those with HA-AKI. The meta-analysis revealed that patients with CA-AKI showed significantly lower in-hospital mortality (odds ratio (OR) = 2.79; Z = 8.22; 95% confidence interval (CI), 2.18 - 3.56; p < 0.001) and shorter length of hospital stay (OR = 2.55; Z = 5.81; 95% CI, 1.86 - 3.50; p < 0.001). Subanalyses of studies conducted in developing and developed countries showed that patients with CA-AKI had lower in-hospital mortality and shorter length of hospital stay. Jackknife sensitivity analyses confirmed the replicability of these findings (p < 0.001).
CONCLUSIONS: The results indicate that significant differences exist in clinical phenotypes between CA- and HA-AKI, even when standardized diagnosis criteria are used. .
尚无全面综述从患者特征、院内死亡率和住院时间长度方面研究社区获得性(CA)与医院获得性(HA)急性肾损伤(AKI)之间的差异。
我们对观察性研究进行了系统综述和荟萃分析,使用MEDLINE、EMBASE、科学网、谷歌学术以及考克兰图书馆自建库至2016年4月10日的数据。纳入的观察性研究需满足以下条件:(1)发表于同行评审期刊;(2)比较CA-AKI与HA-AKI,无论同期的AKI定义如何;(3)研究院内死亡率和住院时间长度。分析患者基线特征的差异,并进行荟萃分析以比较院内死亡率和住院时间长度。
纳入了八项符合条件的观察性研究,共17939例患者。系统综述表明,与HA-AKI患者相比,CA-AKI患者的AKI 3期发生率显著更高。荟萃分析显示,CA-AKI患者的院内死亡率显著更低(比值比(OR)=2.79;Z=8.22;95%置信区间(CI),2.18 - 3.56;p<0.001),住院时间更短(OR=2.55;Z=5.81;95%CI,1.86 - 3.50;p<0.001)。在发展中国家和发达国家进行的研究的亚组分析表明,CA-AKI患者的院内死亡率更低,住院时间更短。逐一剔除法敏感性分析证实了这些发现的可重复性(p<0.001)。
结果表明,即使使用标准化诊断标准,CA-AKI和HA-AKI的临床表型仍存在显著差异。